ANXA2 and cancer: Bearing in mind the association of collagen-I over-expression with migration, invasion, breast cancer metastasis and poor survival (36), we can hypothesize that collagen-I’s influence on Annexin A2 phosphorylation and the subsequent degradation of fibronectin, may be one of the many ways in which the ECM can promote cancer progression.